Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care

PHASE3CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

October 31, 2009

Study Completion Date

February 28, 2010

Conditions
Burn
Interventions
DRUG

DGD

Lyophilized, sterile mixture of proteolyzed enzymes; mixed with gel,for topical application.

Trial Locations (17)

13005

Centre Hospitalier Regional et Universitaire de Marseille, Service de Chirurgie Plastique Reparatrice et Esthetique, Marseille

47023

Centro Grandi Ustionati, Cesena

82107

Center for Burns & Reconstructive Surgery, University Hopsital Bratislava, Bratislava

90127

Direttore U.O. Chirurgia Plastica e Centro Ustioni Ospedale Civico, Palermo

Unknown

Royal Hospital Perth, Perth

Pronto Socorro para Queimaduras de Goiania, Goiânia

Hospital do Servidor Publico do Estado de Sao Paulo, São Paulo

Unfallkrankenhaus Berlin Burn Center, Berlin

BG - Unfallklinik Ludwigshafen, Ludwigshafen

Klinikum Mannheim Universtatsklinikum, Mannheim

Soroka University Medical Center, Beersheba

Wojskowy Instytut Medyczny, Warsaw

"Emergency Clinic Hospital Bagdazar-Arsenie", Bucharest

F-75014

Center Des Brules Hopital Cochin, Paris

04015

Clinic of Burns and Reconstructive Surgery Hospital Kosice, Kosice-Saca

RH19 3DZ

Queen Victoria Hospital, East Grinstead

WF1 4EE

The Burn Center Pinderfields Hospital, Wakefield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MediWound Ltd

INDUSTRY